Journal
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Volume 66, Issue 4, Pages 535-552Publisher
MOSBY-ELSEVIER
DOI: 10.1016/j.jaad.2011.11.961
Keywords
cyclosporine; extracorporeal photopheresis; graft-versus-host disease; hematopoietic cell transplantation; imatinib mesylate; mycophenolate mofetil; phototherapy; tacrolimus; rituximab
Categories
Funding
- National Cancer Institute, Center for Cancer Research
Ask authors/readers for more resources
Dermatologists are ideally suited to manage the various cutaneous sequelae of graft-versus-host disease (GVHD) outlined in part I of this review. However, the complexity of the patient with GVHD, including comorbidities, potential drug interactions related to polypharmacy, and the lack of evidence-based treatment guidelines, are significant challenges to optimizing patient care. In this section, we will provide an outline for the role of the dermatologist in a multispecialty approach to caring for patients with GVHD. (J Am Acad Dermatol 2012;66:535.e1-16.)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available